Related Experiment Video
Updated: Jan 31, 2026

Embolic Middle Cerebral Artery Occlusion MCAO for Ischemic Stroke with Homologous Blood Clots in Rats
Published on: September 17, 2014
Three-year adherence to secondary prevention and vascular risk control after ischemic stroke
Erlend Fagerli1, Hanne Ellekjær2,3, Olav Spigset4,5
1Department of Circulation and Medical Imaging, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Insights
Three years after ischemic stroke, medication adherence was high, but vascular risk factor control remained poor. Enhanced secondary prevention strategies are needed for Norwegian stroke survivors to improve long-term outcomes.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Long-term adherence to secondary prevention strategies after ischemic stroke is crucial but not well understood.
- Evaluating medication adherence and achievement of vascular treatment targets is essential for optimizing post-stroke care.
- Understanding factors influencing target achievement can guide personalized secondary prevention plans.
Purpose of the Study:
- To assess medication adherence and persistence 3 years after ischemic stroke.
- To evaluate the attainment of guideline-based vascular treatment targets (blood pressure, LDL cholesterol, HbA1c).
- To identify clinical characteristics associated with achieving these secondary prevention targets.
Main Methods:
- A cohort of 431 home-dwelling ischemic stroke patients from the Norwegian Cognitive Impairment After Stroke study were followed for 3 years.
- Medication adherence was measured using the Morisky Medication Adherence Scale and medication persistence.
- Treatment targets included blood pressure <140/90 mmHg, LDL cholesterol <2.0 mmol/L, and HbA1c ≤53 mmol/mol.
Main Results:
- High medication persistence rates were observed at 3 years (97% antithrombotics, 91% antihypertensives, 83% lipid-lowering drugs).
- Despite high adherence (73%), target achievement was suboptimal: 42% for blood pressure, 47% for LDL cholesterol.
- Younger age correlated with better blood pressure control; female sex with poorer LDL cholesterol control.
Conclusions:
- Risk factor control remains unsatisfactory 3 years post-ischemic stroke, despite good medication adherence and persistence.
- Specific patient characteristics influence the achievement of vascular treatment targets.
- There is a need for improved implementation of secondary prevention strategies in Norwegian stroke patients.
Introduction:
Long-term adherence to secondary prevention after ischemic stroke remains unclear. This study aimed to evaluate medication adherence, attainment of vascular treatment targets, and clinical characteristics that influence target achievement 3 years post-stroke.
Patients And Methods:
We included 665 home-dwelling ischemic stroke patients from the Norwegian Cognitive Impairment After Stroke study, admitted between May 2015 and March 2017 (n = 431 were followed for 3 years). Medication adherence was assessed using the 4-item Morisky Medication Adherence Scale, medication persistence, and guideline-based treatment targets: blood pressure (BP) < 140/90 mmHg, LDL cholesterol (LDL-C) < 2.0 mmol/L, and hemoglobin A1c (HbA1c) ⩽ 53 mmol/mol.
Results:
At discharge, prescription rates were 97% for antithrombotics, 67% for antihypertensives, 88% for lipid-lowering drugs (LLD), and 10% for antidiabetics. Three years later, persistence rates were 97%, 91%, 83%, and 94%, respectively, with 73% reporting high medication adherence. Target achievement rates were 42% for BP, 47% for LDL-C, and 75% for HbA1c among diabetic patients. Younger age was associated with better BP control (OR 0.974 per year, 95% CI 0.957-0.992). Women had poorer LDL-C control (OR 0.55, 95% CI 0.33-0.91). More LLD (OR 1.25, 95% CI 1.14-1.37) and higher comorbidity (OR 1.26, 95% CI 1.10-1.44) were associated with improved LDL-C control.
Conclusion:
Control of risk factors remained unsatisfactory 3 years after ischemic stroke, despite relatively high persistence and adherence rates. Improved focus on implementing optimal secondary prevention for Norwegian stroke patients is necessary.
Related Concept Videos
Primary and Secondary Growth in Roots and Shoots
Secondary Active Transport
Seedless Vascular Plants
Secondary Healthcare System
Relative Risk
Cancer Prevention
Some...

